Anuh Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2025 ,inter alia, to consider and approve unaudited financial results for ....
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anuh Pharma Ltd has informed BSE and NSE that its Board of Directors will meet on Friday, 08th August, 2025 at the company's registered office. The main agenda is to consider and approve the Un-Audited Financial Results for the quarter ended 30th June, 2025 (Q1 FY26). The filing was made under Regulation 29 of SEBI's Listing Obligations and Disclosure Requirements, 2015. As per insider trading norms, the trading window for designated persons and their immediate relatives has been closed since 01st July, 2025 and will reopen 48 hours after results are declared, on 10th August, 2025. The intimation is signed by Manan Vadhan, Company Secretary & Compliance Officer.
This is a routine regulatory filing ahead of the Q1 FY26 earnings announcement. No immediate stock price impact is expected from this intimation itself; investors should track the actual results to be declared on 08th August, 2025 for any meaningful signals on the company's quarterly performance.